AI-ROSE for diagnosing severe pneumonia
Part of Infections, Lungs & breathing clinical trials.
This trial uses an AI tool called AI-ROSE to analyze lung fluid from a bronchoscopy. It aims to help doctors quickly diagnose severe pneumonia and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a lower respiratory tract infection and severe pneumonia.
- Severe pneumonia means you need a ventilator for breathing or medication for shock, or you have at least 3 other signs like fast breathing, low oxygen levels, confusion, low blood pressure, or abnormal lab results.
- You agree to have a bronchoscopy and a lung wash (lavage) to collect fluid for the AI-ROSE test.
- You cannot have other serious health issues that make bronchoscopy unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether pictures from a lung CT and a bronchoscopy can help doctors quickly find the germ causing severe pneumonia. If you participate, your existing medical records will be reviewed to see if combining these imaging tests with lab tests speeds up diagnosis and improves treatment.
This study uses artificial intelligence to help doctors understand pneumonia in intensive care patients. It may lead to better and faster treatment decisions.
This trial tests a new way to predict how well patients with a ventilator-associated lung infection will respond to treatment. It uses two bronchoscopy samples to track bacteria levels and guide better care.
This study tests whether an artificial intelligence (AI) tool can help doctors quickly examine tissue samples taken during a lung biopsy. It aims to see if the AI can improve the accuracy and speed of diagnosing lung conditions.
This study tests whether an AI-assisted navigation system helps doctors perform bronchoscopies more accurately in people with severe pneumonia. The goal is to improve diagnosis and treatment of severe pneumonia.
This trial tests whether an artificial intelligence (AI) tool can help prevent, diagnose, and triage respiratory diseases. It is open to adults without medical training who can follow a survey.
Hear when a new Severe Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.